J
Jitendra Kumar
Researcher at Jamia Millia Islamia
Publications - 16
Citations - 467
Jitendra Kumar is an academic researcher from Jamia Millia Islamia. The author has contributed to research in topics: Docking (molecular) & Sulfonic acid. The author has an hindex of 9, co-authored 15 publications receiving 345 citations.
Papers
More filters
Journal ArticleDOI
Metal clusters activated SnO2 thin film for low level detection of NH3 gas
TL;DR: In this article, the fabrication of NH3 gas sensor based on SnO2 thin films modified with metallic clusters (MCs) has been reported, and a simple and low-cost sensor structure shows the promising results for the practical realization in NH3 sensing.
Journal ArticleDOI
Coumarin: A Privileged Scaffold for the Design and Development of Antineurodegenerative Agents.
TL;DR: This review undertakes estimation of the wide spectrum of studies focusing coumarin to the domain of drug research for ND, and searches for multitarget cou marin‐based inhibitors and their scope for NDs.
Journal ArticleDOI
Synthesis and screening of triazolopyrimidine scaffold as multi-functional agents for Alzheimer's disease therapies
Jitendra Kumar,Poonam Meena,Anju Singh,Ehtesham Jameel,Mudasir Maqbool,Mohammad Mobashir,Ashutosh Shandilya,Manisha Tiwari,Nasimul Hoda,Bhyravabhotla Jayaram +9 more
TL;DR: In this article, a series of triazolopyrimidine-quinoline and cyanopyridine-quinoline hybrids were designed, synthesized and evaluated as acetylcholinesterase inhibitors (AChEIs).
Journal ArticleDOI
Rational design, synthesis and biological screening of triazine-triazolopyrimidine hybrids as multitarget anti-Alzheimer agents
Ehtesham Jameel,Poonam Meena,Mudasir Maqbool,Jitendra Kumar,Waqar Ahmed,Syed Mumtazuddin,Manisha Tiwari,Nasimul Hoda,Bhyravabhotla Jayaram +8 more
TL;DR: The multitarget profile exerted by these novel triazine molecules qualified them as potential anti-Alzheimer drug candidates in AD therapy and possess very low toxic effects in the primarily pharmacokinetic study.
Journal ArticleDOI
Development of cyanopyridine-triazine hybrids as lead multitarget anti-Alzheimer agents.
Mudasir Maqbool,Apra Manral,Ehtesham Jameel,Jitendra Kumar,Vikas Saini,Ashutosh Shandilya,Manisha Tiwari,Nasimul Hoda,Bhyravabhotla Jayaram +8 more
TL;DR: Results from neuroprotection studies of most potent compounds 4d and 4h indicate that these derivatives can reduce neuronal death induced by H2O2-mediated oxidative stress and Aβ1-42 induced cytotoxicity.